4.8 Meeting Abstract

CHRONIC ADMINISTRATION OF RIFAXIMIN FOR THE MAINTENANCE OF REMISSION OF HEPATIC ENCEPHALOPATHY: A SUBGROUP ANALYSIS OF A PHASE 3 TRIAL

Journal

JOURNAL OF HEPATOLOGY
Volume 50, Issue -, Pages S90-S90

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/S0168-8278(09)60224-5

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available